Ontology type: schema:ScholarlyArticle
2018-08-04
AUTHORSEsther Schuler, Natalie Zadrozny, Sabine Blum, Thomas Schroeder, Corinna Strupp, Barbara Hildebrandt, Andrea Kündgen, Norbert Gattermann, Carlo Aul, Mustafa Kondakci, Guido Kobbe, Rainer Haas, Ulrich Germing
ABSTRACTIntensive chemotherapy (IC) used to be a common treatment approach for patients with higher-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia after MDS (sAML). We conducted a retrospective analysis of 299 patients, including a matched pair analysis comparing 96 patients receiving IC with 96 patients not undergoing IC, in order to evaluate the impact of IC on overall survival (OS) and to identify factors that influence remission rates and OS. Complete remission (CR) after first induction chemotherapy was reached in 50% of patients. Parameters influencing the probability of achieving CR were blast count in the bone marrow (< 30%), age < 65 years, presence of Auer rods, duration of antecedent MDS shorter than 6 months, and timing of IC in relation to first diagnosis. The difference in survival time was not significantly better for patients receiving IC (median OS 12.7 months vs. 7 months). Parameters favorably influencing survival were the presence of Auer rods, age below 60 years, blast count below 30%, IC given shortly after first diagnosis, and achievement of CR. On multivariate analysis, achieving CR, presence of Auer rods, and percentage of blasts below or above 30% significantly influenced median survival. Relapse occurred in 63% of patients after a median of 9.9 months with a median survival of 7.6 months. Considering the high relapse rate and short survival, we conclude that intensive chemotherapy is not promising for high-risk MDS or sAML. More... »
PAGES2325-2332
http://scigraph.springernature.com/pub.10.1007/s00277-018-3466-7
DOIhttp://dx.doi.org/10.1007/s00277-018-3466-7
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1106003360
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30078145
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Age Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease-Free Survival",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myeloid, Acute",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Myelodysplastic Syndromes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Time Factors",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Schuler",
"givenName": "Esther",
"id": "sg:person.01330433074.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330433074.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Zadrozny",
"givenName": "Natalie",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, University Hospital, Lausanne, Switzerland",
"id": "http://www.grid.ac/institutes/grid.8515.9",
"name": [
"Department of Oncology, University Hospital, Lausanne, Switzerland"
],
"type": "Organization"
},
"familyName": "Blum",
"givenName": "Sabine",
"id": "sg:person.01052133152.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052133152.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Schroeder",
"givenName": "Thomas",
"id": "sg:person.01271136615.68",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Strupp",
"givenName": "Corinna",
"id": "sg:person.01001653715.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001653715.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Human Genetics and Anthropology, Heinrich Heine-University, Duesseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Institute of Human Genetics and Anthropology, Heinrich Heine-University, Duesseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Hildebrandt",
"givenName": "Barbara",
"id": "sg:person.01320675564.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320675564.15"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "K\u00fcndgen",
"givenName": "Andrea",
"id": "sg:person.01107510155.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107510155.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Gattermann",
"givenName": "Norbert",
"id": "sg:person.01273447501.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Oncology, Johannes Hospital Duisburg, Duisburg, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology and Oncology, Johannes Hospital Duisburg, Duisburg, Germany"
],
"type": "Organization"
},
"familyName": "Aul",
"givenName": "Carlo",
"id": "sg:person.01300444115.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300444115.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Kondakci",
"givenName": "Mustafa",
"id": "sg:person.01150516001.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Kobbe",
"givenName": "Guido",
"id": "sg:person.01164073234.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Haas",
"givenName": "Rainer",
"id": "sg:person.01127414674.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.411327.2",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Germing",
"givenName": "Ulrich",
"id": "sg:person.01362464041.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/s41409-018-0318-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1107206568",
"https://doi.org/10.1038/s41409-018-0318-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-014-2177-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008533696",
"https://doi.org/10.1007/s00277-014-2177-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-017-3001-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085177784",
"https://doi.org/10.1007/s00277-017-3001-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-015-2486-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049512718",
"https://doi.org/10.1007/s00277-015-2486-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-009-0473-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013341559",
"https://doi.org/10.1007/s12185-009-0473-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2015.244",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020863319",
"https://doi.org/10.1038/leu.2015.244"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11899-015-0276-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016887310",
"https://doi.org/10.1007/s11899-015-0276-z"
],
"type": "CreativeWork"
}
],
"datePublished": "2018-08-04",
"datePublishedReg": "2018-08-04",
"description": "Intensive chemotherapy (IC) used to be a common treatment approach for patients with higher-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia after MDS (sAML). We conducted a retrospective analysis of 299 patients, including a matched pair analysis comparing 96 patients receiving IC with 96 patients not undergoing IC, in order to evaluate the impact of IC on overall survival (OS) and to identify factors that influence remission rates and OS. Complete remission (CR) after first induction chemotherapy was reached in 50% of patients. Parameters influencing the probability of achieving CR were blast count in the bone marrow (<\u200930%), age <\u200965\u00a0years, presence of Auer rods, duration of antecedent MDS shorter than 6\u00a0months, and timing of IC in relation to first diagnosis. The difference in survival time was not significantly better for patients receiving IC (median OS 12.7\u00a0months vs. 7\u00a0months). Parameters favorably influencing survival were the presence of Auer rods, age below 60\u00a0years, blast count below 30%, IC given shortly after first diagnosis, and achievement of CR. On multivariate analysis, achieving CR, presence of Auer rods, and percentage of blasts below or above 30% significantly influenced median survival. Relapse occurred in 63% of patients after a median of 9.9\u00a0months with a median survival of 7.6\u00a0months. Considering the high relapse rate and short survival, we conclude that intensive chemotherapy is not promising for high-risk MDS or sAML.",
"genre": "article",
"id": "sg:pub.10.1007/s00277-018-3466-7",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1358129",
"issn": [
"0939-5555",
"1432-0584"
],
"name": "Annals of Hematology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "12",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "97"
}
],
"keywords": [
"high-risk myelodysplastic syndrome",
"intensive chemotherapy",
"complete remission",
"myelodysplastic syndrome",
"acute myeloid leukemia",
"overall survival",
"Auer rods",
"median survival",
"blast count",
"first diagnosis",
"myeloid leukemia",
"achievement of CR",
"secondary acute myeloid leukemia",
"high-risk patients",
"percentage of blasts",
"antecedent myelodysplastic syndrome",
"long-term outcomes",
"first induction chemotherapy",
"high relapse rate",
"common treatment approach",
"induction chemotherapy",
"remission rate",
"relapse rate",
"risk patients",
"shorter survival",
"retrospective analysis",
"survival time",
"patients",
"treatment approaches",
"bone marrow",
"chemotherapy",
"multivariate analysis",
"survival",
"months",
"syndrome",
"leukemia",
"diagnosis",
"age",
"pair analysis",
"count",
"remission",
"relapse",
"years",
"marrow",
"median",
"outcomes",
"duration",
"presence",
"rate",
"percentage",
"blasts",
"factors",
"differences",
"analysis",
"timing",
"impact",
"time",
"rods",
"parameters",
"relation",
"SAML",
"probability",
"approach",
"achievement",
"order"
],
"name": "Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy",
"pagination": "2325-2332",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1106003360"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00277-018-3466-7"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30078145"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00277-018-3466-7",
"https://app.dimensions.ai/details/publication/pub.1106003360"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:05",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_785.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00277-018-3466-7"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3466-7'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3466-7'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3466-7'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3466-7'
This table displays all metadata directly associated to this object as RDF triples.
305 TRIPLES
21 PREDICATES
112 URIs
97 LITERALS
22 BLANK NODES